Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial

Documenti analoghi

• In-vivo quantification of hypoxic and metabolic status of NSCLC tumors using [(18)F]HX4 and [(18)F]FDG PET/CT imaging
  di: Zegers, Catharina M.L., et al.
  Pubblicazione: (2014)
• Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion
  di: van Elmpt, Wouter, et al.
  Pubblicazione: (2015)
• Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities
  di: van Elmpt, Wouter, et al.
  Pubblicazione: (2014)
• Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach
  di: Even, Aniek J.G., et al.
  Pubblicazione: (2016)
• Should patient set-up in lung cancer be based on the primary tumor? An analysis of tumor coverage and normal tissue dose using repeated PET/CT imaging
  di: van Elmpt, Wouter, et al.
  Pubblicazione: (2010)